Nammi Therapeutics, Inc.
Company Details
Status: Private
Employees: 1-10
Location:
10940 WILSHIRE BLVD, STE 600, Los Angeles, CA 90024, US
Type:
sample
Technology:
sample
sample
sample
sample
About: Nammi Therapeutics, Inc. is an immuno-oncology company based in Los Angeles that is developing platforms and products that selectively activate anti-tumor immunity within the tumor microenvironment while minimizing systemic activation. By reducing systemic activation of the immune system, Nammi expects to improve safety and enhance the ability to combine multiple immune modulators. Nammi's lead product candidate, QXL138AM, is a Masked Immunocytokine (MIC) targeting a masked interferon to the tumor antigen, CD138. In addition to the MIC platform, Nammi has also developed a nanoparticle platform to deliver Immune Modulating Prodrugs (IMPs) using their Nammisome technology. Multiple Nammisome clinical candidates have also been selected for development.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Nammi Therapeutics, Inc. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.